[go: up one dir, main page]

FI20060768A0 - Erityisesti metabolia-oireyhtymän hoitoon tai ehkäisyyn soveltuvia koostumuksia - Google Patents

Erityisesti metabolia-oireyhtymän hoitoon tai ehkäisyyn soveltuvia koostumuksia

Info

Publication number
FI20060768A0
FI20060768A0 FI20060768A FI20060768A FI20060768A0 FI 20060768 A0 FI20060768 A0 FI 20060768A0 FI 20060768 A FI20060768 A FI 20060768A FI 20060768 A FI20060768 A FI 20060768A FI 20060768 A0 FI20060768 A0 FI 20060768A0
Authority
FI
Finland
Prior art keywords
treating
especially suitable
metabolic syndrome
preventing metabolic
compositions especially
Prior art date
Application number
FI20060768A
Other languages
English (en)
Swedish (sv)
Inventor
Sirpa Jalkanen
Marko Salmi
Markku Jalkanen
Original Assignee
Faron Pharmaceuticals Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Faron Pharmaceuticals Oy filed Critical Faron Pharmaceuticals Oy
Priority to FI20060768A priority Critical patent/FI20060768A0/fi
Publication of FI20060768A0 publication Critical patent/FI20060768A0/fi
Priority to PCT/FI2007/000206 priority patent/WO2008025870A1/en
Priority to EP07803696A priority patent/EP2056830A4/en
Priority to US12/060,533 priority patent/US8119651B2/en
Priority to US13/354,025 priority patent/US20120115815A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/24Radicals substituted by oxygen atoms
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15Vitamins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • A61K31/4261,3-Thiazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A61K31/51Thiamines, e.g. vitamin B1
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/675Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Polymers & Plastics (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FI20060768A 2004-01-30 2006-08-28 Erityisesti metabolia-oireyhtymän hoitoon tai ehkäisyyn soveltuvia koostumuksia FI20060768A0 (fi)

Priority Applications (5)

Application Number Priority Date Filing Date Title
FI20060768A FI20060768A0 (fi) 2006-08-28 2006-08-28 Erityisesti metabolia-oireyhtymän hoitoon tai ehkäisyyn soveltuvia koostumuksia
PCT/FI2007/000206 WO2008025870A1 (en) 2006-08-28 2007-08-22 Compositions useful especially for treatment or prevention of metabolic syndrome
EP07803696A EP2056830A4 (en) 2006-08-28 2007-08-22 SPECIAL COMPOSITIONS FOR TREATMENT OR PREVENTION OF METABOLIC SYNDROME
US12/060,533 US8119651B2 (en) 2004-01-30 2008-04-01 Compositions useful especially for treatment or prevention of metabolic syndrome
US13/354,025 US20120115815A1 (en) 2004-01-30 2012-01-19 Compositions useful especially for treatment or prevention of metabolic syndrome

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FI20060768A FI20060768A0 (fi) 2006-08-28 2006-08-28 Erityisesti metabolia-oireyhtymän hoitoon tai ehkäisyyn soveltuvia koostumuksia

Publications (1)

Publication Number Publication Date
FI20060768A0 true FI20060768A0 (fi) 2006-08-28

Family

ID=36950669

Family Applications (1)

Application Number Title Priority Date Filing Date
FI20060768A FI20060768A0 (fi) 2004-01-30 2006-08-28 Erityisesti metabolia-oireyhtymän hoitoon tai ehkäisyyn soveltuvia koostumuksia

Country Status (3)

Country Link
EP (1) EP2056830A4 (fi)
FI (1) FI20060768A0 (fi)
WO (1) WO2008025870A1 (fi)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009023207A1 (en) * 2007-08-13 2009-02-19 Synvista Therapeutics, Inc. Thiazolium compounds for treating gastrointestinal complications
WO2009051804A1 (en) * 2007-10-18 2009-04-23 Synvista Therapeutics, Inc. Thiazolium compounds for treating or preventing diseases associated with insulin resistance
US8906642B2 (en) 2008-09-03 2014-12-09 Universitat Autonoma De Barcelona Methods and compositions for the treatment and diagnosis of haemorrhagic conversion
AU2014279863A1 (en) 2013-06-12 2016-01-28 Proximagen Limited New therapeutic uses of enzyme inhibitors
WO2015189534A1 (en) 2014-06-12 2015-12-17 Proximagen Limited Vap-1 inhibitors for treating muscular dystrophy
AU2016366635A1 (en) 2015-12-07 2018-06-21 Benevolentai Cambridge Limited VAP-1 inhibitors for treating pain
US20220354847A1 (en) * 2019-09-26 2022-11-10 The State Of Israel, Ministry Of Agriculture & Rural Development, Agricultural Research Organization Thiamine therapy for fatty liver associated diseases

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4558050A (en) * 1984-03-01 1985-12-10 University Of Florida Treatment of metabolic disorders with dichloroacetate-thiamine preparations
CA2066951A1 (en) * 1991-04-26 1992-10-27 Kou Moriyama Edible composition
US5853703A (en) * 1995-01-18 1998-12-29 The Picower Institute For Medical Research Preventing and reversing the formation of advanced glycosylation endproducts
DE19629802A1 (de) * 1996-07-24 1998-01-29 Woerwag Pharma Gmbh Arzneimittel zur Behandlung von Neuropathien
DE19629803A1 (de) * 1996-07-24 1998-01-29 Woerwag Pharma Gmbh Arzneimittel zur Behandlung von Neuropathien
DE10353535A1 (de) * 2003-11-14 2005-06-16 Bayer Healthcare Ag Vitaminkombination, enthaltend Benfotiamin
JP2007519688A (ja) * 2004-01-30 2007-07-19 ファロン ファーマシューティカルズ オサケ ユキチュア メタボリックシンドロームの治療または予防に特に有効な組成物
US20090209554A1 (en) * 2004-03-24 2009-08-20 Array Biopharma Inc. Thiazoliums as transketolase inhibitors
JP2006008576A (ja) * 2004-06-25 2006-01-12 Kosei Tanaka ヘキサミン生合成経路活性化抑制剤
US20060089316A1 (en) * 2004-10-25 2006-04-27 Brown Truman R Method for reducing a susceptibility to tumor formation induced by 3-deoxyglucosone and precursors thereof

Also Published As

Publication number Publication date
WO2008025870A1 (en) 2008-03-06
EP2056830A1 (en) 2009-05-13
EP2056830A4 (en) 2011-01-12

Similar Documents

Publication Publication Date Title
FR18C1052I2 (fr) Compositions fongicides
DE602007012330D1 (de) Beschichtungszusammensetzung
ZA200904972B (en) Novel composition for treating metabolic syndrome
FR2899479B1 (fr) Composition cicatrisante
BRPI0715712A2 (pt) Composição farmacêutica
BRPI0813775A2 (pt) Composição
ATE528048T1 (de) Schweisshemmende/desodorierende zusammensetzung
BRPI0719393A2 (pt) Composição farmacêutica
ATE485357T1 (de) Geschirrspülzusammensetzung
EP2112208A4 (en) COATING COMPOSITION
BRPI0716445A2 (pt) composiÇço farmacÊutica
BRPI0810557A2 (pt) composição
DE602007002320D1 (de) Antibeschlagbeschichtungszusammensetzung
BRPI0811274A2 (pt) Composição
BRPI0817666A2 (pt) Composição com proteção uv
FR2905563B1 (fr) Composition alimentaire.
FI20060768A0 (fi) Erityisesti metabolia-oireyhtymän hoitoon tai ehkäisyyn soveltuvia koostumuksia
ITMI20061291A1 (it) Composizioni (per) fluoroelastomeriche
FI20075086A0 (fi) Aromikoostumus
FR2898899B1 (fr) Composition photoreticulable
FR2923713B1 (fr) Composition reductrice epaissie.
EP2188349A4 (en) OXYGEN ABSORBING COMPOSITION
EP2229934A4 (en) MICRO PARTICLE FILM COMPOSITION
DE602007004857D1 (de) Zusammensetzungen mit verbesserter elastifizierungswirkung
BRPI0812584A2 (pt) Composições inseticidas com efeito melhorado

Legal Events

Date Code Title Description
FD Application lapsed